Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Introduction to Treatment

• The American Academy of Pediatrics recommends a treatment approach based on age, with stimulant medications as the first line for school-aged children (6-11 years) and adolescents (12-18 years), while behavioral therapy should be the first option for preschoolers (4-5 years) 1
• The American Academy of Pediatrics recommends FDA-approved medications with the adolescent's assent as a primary treatment for ADHD, and evidence-based training interventions and behavioral therapy are also recommended as a primary treatment for ADHD 2, 1

Medication Treatment

• The American Academy of Pediatrics recommends FDA-approved medications, preferably combined with behavioral therapy, with strong evidence for stimulant medications (effect size of approximately 1.0) and sufficient but less strong evidence for atomoxetine (effect size of approximately 0.7), guanfacine extended release, and clonidine extended release 1, 2, 3
• Non-stimulant medications, such as atomoxetine, may be preferred in patients with comorbid anxiety or depression, substance abuse concerns, or tic disorders/Tourette's syndrome, with extended-release guanfacine and extended-release clonidine as alternative options 3, 2, 1, 4
• Stimulants have high potential for abuse and misuse, and assessing each patient's risk for abuse before prescribing is crucial 2, 3, 1

Behavioral Therapy

• Behavioral therapy administered by parents and/or teachers is the first line of treatment for preschoolers (4-5 years), and may be prescribed in combination with medication for other age groups 1
• Cognitive-Behavioral Therapy (CBT) is the most extensively studied and effective psychotherapy for adult ADHD, focusing on time management, organization, planning, emotional self-regulation, and impulse control, and is most effective when combined with medication 3
• Mindfulness-Based Interventions (MBIs) have rapidly increasing evidence for adult ADHD management, including improvements in inattention symptoms, emotion regulation, executive function, and overall quality of life 3
• Parent/Family Training and Organizational Skills Training are beneficial, especially when continued over extended periods with frequent performance feedback 2

Educational Interventions

• Educational interventions, including individualized instructional supports, appropriate school environment adjustments, class placement considerations, and often an Individualized Education Program (IEP), are a necessary component of ADHD treatment, as recommended by the American Academy of Pediatrics 2

Ongoing Management

• The American Academy of Pediatrics recommends that ADHD be recognized as a chronic condition requiring ongoing management, with medication doses titrated to achieve maximum benefit with minimal adverse effects, and periodic reevaluation of the long-term usefulness of medication 1
• Regular assessment of treatment efficacy and adverse effects is necessary, as well as screening and treatment of common comorbid conditions such as anxiety, depression, and learning disorders 2, 1, 3
• Regular monitoring of side effects, vital signs, weight, and psychiatric symptoms is necessary, especially with certain medications like guanfacine and atomoxetine 4, 1
• Discontinuing treatment can lead to worse outcomes, as longitudinal studies show greater risk of significant problems if treatment is discontinued 1

International Variations in Treatment

• Western guidelines typically recommend medications plus behavioral therapy as first-line treatment, while some Asian guidelines recommend school environment management and psychosocial treatment as first-line, with medication as second-line 5
• The Japanese guidelines differ by recommending non-stimulants as first-line options, highlighting country-specific variations in treatment approaches 5

5